Go back

Parliament backs reinforcement of European Medicines Agency

Image: Alessandro Zappalorto, via Shutterstock

MEPs want stronger clinical trial coordination role for EMA, such as helping to find sponsors

The European Parliament has agreed that the European Medicines Agency, which regulates medical treatments in the EU, should be given an expanded remit, including on the coordination of cross-border clinical trials.

On 8 July, 587 MEPs voted to broaden the scope of the law underpinning the EMA, with just 28 opposed. Changes to the agency were proposed by the European Commission in November 2020, after the scramble to conduct coordinated trials during the first wave of the Covid-19 pandemic.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.